MindMed Teams Up With Forian To Improve Real-World Evidence Data To Help Psychiatric Patients
Psychedelics-focused medicines company Mind Medicine Inc. (NASDAQ: MNMD), (NEO: MMED) announced Tuesday that it has teamed up with Forian Inc.
MindMed Announces Collaboration With Forian To Advance Development Of Personalized Psychiatry For Anxiety Disorders
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, has agreed to work with Forian Inc. (NASDAQ:FORA), a
Forian Q2 Sales $4.50M Up From $2.95M YoY
Forian (NASDAQ:FORA) reported $4.50 million in sales this quarter. This is a 52.59 percent increase over sales of $2.95 million the same period last year.
Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell
• Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
